Pharma Advisory Deck
9 slides to send to pharma companies
Pharma Advisory
Business development advisory, by executives, for executives
Actionable BD&L and M&A targets for pharma and biotech companies worldwide
SBTech Global | A global healthcare advisory group | 2026
Who we are
A healthcare business development advisory group. By executives, for executives.
- Support the execution of corporate and BD strategies
- Identify and connect with potential BD&L and M&A opportunities
- Combine advisory and hands-on services at all stages of the value chain
- Deliver actionable support driven by real-world experience
- Led by industry veterans and a global network of C-level advisors
Create and develop NewCo around IP
Develop R&D infrastructure
Out-license / M&A / strategic partnership
Scale-up support
Develop commercial infrastructure
Plan and develop global distribution network
In-license / M&A / strategic partnership
Three complementary activities
Advisory is the entry point; the group connects clients to the full value chain.
Business Development Advisory
Our core focus
- BD&L and M&A scouting and facilitating (seller / buyer)
- New deals, realignment, collaboration or divestiture
- Executive advisory board for C-level and BD teams
- Building local and regional companies
Client needs are mapped and potential solutions from other SBTech businesses are discussed.
Pharma Development Services
Group activity
- Full or tailored outsourced solutions, from idea to patient
- Turnkey or a-la-carte, early stage to start-up scale-up
- Large pharma infrastructure realignment
- Global named patient supply
Clients seeking specific services may also seek partnerships, licensing, co-development or investment.
Specialty Pharma Distribution
Group activity
- TrueMed: standalone Israeli specialty care and rare disease distributor
- Represents some of the most advanced technology innovators in the world
Distribution services for clients expanding into new markets; products we find may suit partners elsewhere.
Business advisory: actionable targets
Delivering actionable targets based on real-world experience
Hands-on support
Project team of executive advisors and staff
Wide network
Current and former healthcare executives and their networks
Actionable targets
We scout, engage and deliver targets which fit the client
Global operation
Key offices in Israel, Switzerland and the US
Off the radar
Targets not yet on the radar of many biopharma and banks
Discreet engagement
Privacy screen and alternative channels when needed
Executive advisory board
For BD teams and executives seeking an experienced perspective
Our boundaries
A continuous source of opportunities
Multiple channels generate deal flow that cross-pollinates across all of SBTech's activities.
Independent executive advisors sit on 50+ boards and advisory groups
Relationships with innovation channels such as private equity and venture funds
Distributors in various territories give insight into local opportunities with global potential
SBTech's Pharma Services division sells solutions to early and late stage pharma
Private investors seeking to optimize their investments
Independent executive advisors
Former and current leaders of global pharma, who sit on 50+ boards and advisory groups
Hans Peter Hasler
Head Advisor. Chairman, HBM Healthcare. Former COO Biogen, COO Elan, CMO Wyeth
Gwen Melincoff
Board at Gain, Protalix, Soleno. Former VP BD at BTG, SVP BD & Investing at Shire
Chris Adams
Rare disease BD advisor. Former Founder & CEO Cydan, CBO FoldRx
Eric Richman
Board at Gain Tx, Neubase. Former CEO PharmAthene, Int. Commercialization at MedImmune
Tony Rosenberg
Chairman at Oculis. Board at Cullinan, argenx. Former MD at MPM Capital, Head of M&A at Novartis
Christophe Jean
Partner at ORAXYS. Former Head of CD & M&A at IPSEN, President Europe Pharma at Novartis
Klaus Schollmeier
Venture coach at Chemovator. Former CEO SuppreMol, Santhera, Graffinity
Jeff Berkowitz
CEO Real Endpoints. Board at Lundbeck, Esperion, Zealand. Former EVP UnitedHealth
Anthony Sun
CEO at Zentera Tx. Board at Neurelis. Former CEO Zentalis, Partner at Aisling
Mark Wolters
Board at Celmatix. Advisor to Zumutor Biologics. Former Head of Early Licensing at Bayer
Partial list. Biographies do not include all former positions and affiliations.
Trusted by pharma worldwide
Services for companies of various sizes, development phases and geographic footprints
Partial client list, past and present, based on disclosure pre-approval. Distribution deals are done by SBTech's distribution company, TrueMed Therapeutics.
Global reach, executive-level delivery
A project team of executive advisors and experienced staff on every engagement
~60
FTEs worldwide
3
Key hubs: Israel, USA, Switzerland
50+
Boards and advisory groups our advisors sit on
20+
Pharma and biotech clients served
Discreet
We may engage targets discreetly to ascertain fit, with a privacy screen when possible.
Hands-on
Advisors and staff work alongside your BD team through execution.
Connected
Local distributor and investor insights feed a global view of opportunity.
Let's talk about your next deal
SBTech is a group led by global healthcare executives, providing hands-on support and advice based on extensive real-world experience.
By Executives, for Executives.
sbtechglobal.com
linkedin.com/company/sbtech-global
© SBTech Global. All rights reserved. This presentation is provided solely for evaluation of the information contained within. No part may be reproduced, stored or retransmitted without prior written permission from SBTech Ltd.